Validation of HealthCare Standards in Chronic Obstructive Pulmonary Disease
VESALIO
1 other identifier
observational
600
1 country
1
Brief Summary
VESALIO is a pilot study aimed at evaluating the feasibility and reliability (time stability and interobserver reliability) of healthcare quality standards in chronic obstructive pulmonary disease (COPD) recently outlined by SEPAR (Spanish Pneumology and Thoracic Surgery Society), and at establishing the foundation for a future validation (construct and criterion validation) of the aforementioned standards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 21, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2012
CompletedMarch 6, 2012
February 1, 2012
February 21, 2012
March 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
COPD exacerbation
Within 12 months after hospitalization
Mortality
within 90 and 180 days after hospitalization
Healthcare-associated cost
Hospital-stay lenght ER visits
within 12 months after hospitalization
Study Arms (1)
COPD Exacerbation Cohort
Patients hospitalized for a COPD exacerbation
Eligibility Criteria
COPD patients hospitalized for an exacerbation of COPD
You may qualify if:
- Men and women 40 years of age or older
- Diagnosis of COPD at hospital discharge
- Hospitalization for a COPD exacerbation
You may not qualify if:
- Patients hospitalized for the first time at the participating site without a documented history of COPD
- Patients currently participating of having ever participated in a COPD-related clinical trial
- Patients with a serious disease that might affect the measured outcomes (terminal oncologic disease, neoplastic disease for which the patient is receiving chemo/radiotherapy, terminal renal insufficiency, AIDS)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital General de Requena
Requena, Valencia, 46340, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan J Soler Cataluna, MD, PhD
Hospital de Requena, Valencia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 21, 2012
First Posted
March 6, 2012
Study Start
February 1, 2010
Last Updated
March 6, 2012
Record last verified: 2012-02